Education
About Us
Working with TipRanks
Follow Us
UG Healthcare Corp. Ltd. (SG:8K7)
SGX:8K7
RESEARCH TOOLSreports
8K7 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeS$0.10 - S$0.14
Previous CloseN/A
Volume145.10K
Average Volume (3M)166.49K
Market Cap
S$68.00M
Enterprise ValueN/A
Total Cash (Recent Filing)S$45.13M
Total Debt (Recent Filing)S$28.46M
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Sep 01, 2025EPS EstimateN/A
Last Dividend Ex-Date
Nov 17, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding623,825,800
10 Day Avg. Volume53,810
30 Day Avg. Volume166,486
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
UG Healthcare Corp. Ltd. News
PremiumCompany Announcements
UG Healthcare Announces Leadership Restructuring and Board Reconstitution
PremiumCompany Announcements
UG Healthcare Expands Control in US Market with UG USA Stake IncreasePremiumCompany Announcements
UG Healthcare Announces Key Board Restructuring
PremiumCompany Announcements
UG Healthcare Corp. Holds Annual General Meeting
PremiumCompany Announcements
UG Healthcare Bolsters European Footprint
PremiumCompany Announcements
UG Healthcare Bolsters Stake in Nigerian Diagnostic JV8K7 FAQ
What was UG Healthcare Corp. Ltd.’s price range in the past 12 months?
UG Healthcare Corp. Ltd. lowest share price was S$0.10 and its highest was S$0.14 in the past 12 months.
What is UG Healthcare Corp. Ltd.’s market cap?
UG Healthcare Corp. Ltd.’s market cap is S$68.00M.
When is UG Healthcare Corp. Ltd.’s upcoming earnings report date?
UG Healthcare Corp. Ltd.’s upcoming earnings report date is Sep 01, 2025 which is in 71 days.
How were UG Healthcare Corp. Ltd.’s earnings last quarter?
UG Healthcare Corp. Ltd. released its earnings results on Feb 14, 2025. The company reported -S$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.002.
Is UG Healthcare Corp. Ltd. overvalued?
According to Wall Street analysts UG Healthcare Corp. Ltd.’s price is currently Overvalued.
Does UG Healthcare Corp. Ltd. pay dividends?
UG Healthcare Corp. Ltd. pays a Notavailable dividend of S$0.003 which represents an annual dividend yield of N/A. See more information on UG Healthcare Corp. Ltd. dividends here
What is UG Healthcare Corp. Ltd.’s EPS estimate?
UG Healthcare Corp. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does UG Healthcare Corp. Ltd. have?
UG Healthcare Corp. Ltd. has 623,825,800 shares outstanding.
What happened to UG Healthcare Corp. Ltd.’s price movement after its last earnings report?
UG Healthcare Corp. Ltd. reported an EPS of -S$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of UG Healthcare Corp. Ltd.?
Currently, no hedge funds are holding shares in SG:8K7
Company Description
UG Healthcare Corp. Ltd.
UG Healthcare Corporation Limited, an investment holding company, manufactures and sells disposable gloves. It operates through three segments: Latex Examination Gloves, Nitrile Examination Gloves, and Other Ancillary Products. The company offers latex examination gloves that comprise single chlorinated and double chlorinated polymer coated gloves, as well as nitrile examination gloves. It also distributes ancillary products, including surgical gloves, vinyl and cleanroom disposable gloves, face masks, and other medical disposables, as well as shoe covers and other related products; and provides business and management consultancy services. The company's products are used in healthcare, food and beverage, industrial, high technology manufacturing, automotive, research and development, and beauty sectors. It serves customers under the Unigloves brand name in Malaysia, Europe, North America, South America, Africa, and rest of Asia. The company was founded in 1989 and is based in Singapore.
Technical Analysis
Riverstone Holdings
―
Hyphens Pharma International Ltd.
―
Medtecs International Corporation Ltd.
―
Pharmesis International Ltd.
―
Econ Healthcare (Asia) Limited
―